lobbying_activities: 2863621

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2863621	642f3704-2a82-4f5f-acab-0f1f052cb1a2	Q3	DAVE KOLBE CONSULTING	401104329	PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION	2022	third_quarter	PHA	Reauthorization of the Prescription Drug User Fee Act (PDUFA) - Support for a strong PDUFA reauthorization that ensures Americans will continue to have first access to life-saving biopharmaceutical medicines throughout the length of the reauthorization. Waiver of Certain Obligations under the WTO Agreement on Trade Related Aspects of Intellectual Property Rights for COVID-19 to also cover Therapeutics and Diagnostics.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2022-10-12T19:08:42-04:00